Physician
Family Medicine
Dr. Robert Ulrich, MD
|
|
Give Review
Dr. Robert Ulrich practices Family Medicine. He studied medicine at Oregon Health & Science University School of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification". Doctor Robert Ulrich, MD is a published physician. He has 101 papers published. The most current publication "Development of engineered vaccines effective against structurally related bacterial superantigens." He is registered with Medicare and accepts Medicare payments.
Publications
- Measurement of the Top Quark Pair Production Cross Section in Proton-Proton Collisions at sqrt[s]=13  TeV.
- Study of B Meson Production in p+Pb Collisions at sqrt[s_{NN}]=5.02  TeV Using Exclusive Hadronic Decays.
- Characterization of cellular immune response and innate immune signaling in human and nonhuman primate primary mononuclear cells exposed to Burkholderia mallei.
- Determination of Specific Antibody Responses to the Six Species of Ebola and Marburg Viruses by Multiplexed Protein Microarrays.
- Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.
- Enhancement of Serum and Mucosal Immune Responses to Haemophilus influenzae Type B Vaccine by Intranasal Delivery.
- Analysis of protein tyrosine phosphatase interactions with microarrayed phosphopeptide substrates using imaging mass spectrometry.
- Biomolecular Interactions of small-molecule inhibitors affecting the YopH protein tyrosine phosphatase.
- Rapid deamidation of recombinant protective antigen when adsorbed on aluminum hydroxide gel correlates with reduced potency of vaccine.
- Structural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-IIalpha.
- Production and purification of a recombinant Staphylococcal enterotoxin B vaccine candidate expressed in Escherichia coli.
- Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon.
- Mucosal tolerance to a bacterial superantigen indicates a novel pathway to prevent toxic shock.
- Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines.
- Regulation of HLA-DR and co-stimulatory molecule expression on natural killer T cells by granulocyte-macrophage colony-stimulating factor.
- Zinc binding and dimerization of Streptococcus pyogenes pyrogenic exotoxin C are not essential for T-cell stimulation.
- Prediction of the multimeric assembly of staphylococcal enterotoxin A with cell-surface protein receptors.
- Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs.
- Correlation of body temperature with protection against staphylococcal enterotoxin B exposure and use in determining vaccine dose-schedule.
- Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity.
- CD56+-T-cell responses to bacterial superantigens and immune recognition of attenuated vaccines.
- Toll-like receptor and cytokine expression patterns of CD56+ T cells are similar to natural killer cells in response to infection with Venezuelan equine encephalitis v...
- Novel protein-protein interactions of the Yersinia pestis type III secretion system elucidated with a matrix analysis by surface plasmon resonance and mass spectrometry.
- Detection of Staphylococcus aureus enterotoxin A and B genes with PCR-EIA and a hand-held electrochemical sensor.
- Human monocytes infected with Yersinia pestis express cell surface TLR9 and differentiate into dendritic cells.
- Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.
- Persistence of zinc-binding bacterial superantigens at the surface of antigen-presenting cells contributes to the extreme potency of these superantigens as T-cell acti...
- Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine.
- Human cytolytic T cell recognition of Yersinia pestis virulence proteins that target innate immune responses.
- Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.
- Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome.
- Interleukin-15 increases vaccine efficacy through a mechanism linked to dendritic cell maturation and enhanced antibody titers.
- An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic sh...
- Vaccine based on a ubiquitous cysteinyl protease and streptococcal pyrogenic exotoxin A protects against Streptococcus pyogenes sepsis and toxic shock.
- Extensive antibody cross-reactivity among infectious gram-negative bacteria revealed by proteome microarray analysis.
- Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
- Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine.
- Optimization of protein solubilization for the analysis of the CD14 human monocyte membrane proteome using LC-MS/MS.
- A rapid oxime linker-based library approach to identification of bivalent inhibitors of the Yersinia pestis protein-tyrosine phosphatase, YopH.
- Staphylococcal enterotoxin A induction of pro-inflammatory cytokines and lethality in mice is primarily dependent on MyD88.
- MyD88-dependent pro-inflammatory cytokine response contributes to lethal toxicity of staphylococcal enterotoxin B in mice.
- Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.
- Analysis of the human immune response to vaccinia by use of a novel protein microarray suggests that antibodies recognize less than 10% of the total viral proteome.
- Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination.
- Antibody recognition of the dengue virus proteome and implications for development of vaccines.
- Activation of MyD88 signaling upon staphylococcal enterotoxin binding to MHC class II molecules.
- Evaluation of the effect of syringe surfaces on protein formulations.
- Nasal immunity to staphylococcal toxic shock is controlled by the nasopharynx-associated lymphoid tissue.
- Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosph...
- Protein microarrays and biomarkers of infectious disease.
- A small molecule that mimics the BB-loop in the Toll interleukin-1 (IL-1) receptor domain of MyD88 attenuates staphylococcal enterotoxin B-induced pro-inflammatory cyt...
- Isothiazolidinone (IZD) as a phosphoryl mimetic in inhibitors of the Yersinia pestis protein tyrosine phosphatase YopH.
- Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model.
- Staphylococcal enterotoxin A and toxic shock syndrome toxin compete with CD4 for human major histocompatibility complex class II binding.
- Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A.
- Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II r...
- Development of engineered vaccines effective against structurally related bacterial superantigens.
- Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release.
- Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity.
- Weak anamnestic responses of inbred mice to Yersinia F1 genetic vaccine are overcome by boosting with F1 polypeptide while outbred mice remain nonresponsive.
- Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens.
- IL-15-induced conversion of monocytes to mature dendritic cells.
- Staphylococcal enterotoxins A and B share a common structural motif for binding class II major histocompatibility complex molecules.
- Anthrax vaccine powder formulations for nasal mucosal delivery.
- Divergence of human and nonhuman primate lymphocyte responses to bacterial superantigens.
- Are DNA-based vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test case.
- Bacterial superantigens in human disease: structure, function and diversity.
- A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogeni...
- Laboratory exposures to staphylococcal enterotoxin B.
- DNA vaccination of mice with a plasmid encoding Puumala hantavirus nucleocapsid protein mimics the B-cell response induced by virus infection.
- Alloreactive T cell recognition of the HLA-DR beta N-terminal polymorphic region.
- Interaction of monoclonal antibodies directed against bromodeoxyuridine with pyrimidine bases, nucleosides, and DNA.
- Evolving superantigens of Staphylococcus aureus.
- DR beta peptides block the antigen-specific response but not the alloresponse of a dual-reactive T-cell clone.
- Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model.
- New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge.
- Monoclonal antibodies against human DNA polymerase-alpha inhibit DNA replication in permeabilized human cells.
- Yeast-expressed hantavirus Dobrava nucleocapsid protein induces a strong, long-lasting, and highly cross-reactive immune response in mice.
- HLA-DR peptide inhibits HIV-induced syncytia.
- In vitro human tissue models in risk assessment: report of a consensus-building workshop.
- Correlation of the highest-energy cosmic rays with nearby extragalactic objects.
- Measurement of the depth of maximum of extensive air showers above 10{18} eV.
- Upper limit on the diffuse flux of ultrahigh energy tau neutrinos from the Pierre Auger Observatory.
- Observation of the suppression of the flux of cosmic rays above 4 x 10 (19) eV.
- Fine mapping of HIV-1 Nef-epitopes by monoclonal antibodies.
- Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
- Plasma compatibility of injectables: comparison of intravenous U-74006F, a 21-aminosteroid antioxidant, with Dilantin brand of parenteral phenytoin.
- Size and position of truncations in the carboxy-terminal region of major capsid protein VP1 of hamster polyomavirus expressed in yeast determine its assembly capacity.
- Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen.
- Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
- Network "Rodent-borne pathogens" in Germany: longitudinal studies on the geographical distribution and prevalence of hantavirus infections.
- The significance of superantigens.
- Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of c...
- Identification of dioxin-responsive genes in Hep G2 cells using differential mRNA display RT-PCR.
- A chemiluminescence detection method of hantaviral antigens in neutralisation assays and inhibitor studies.
- Induction of neutral proteinase and prostanoid production in bovine nasal chondrocytes by interleukin-1 and tumor necrosis factor alpha: modulation of these cellular r...
- Immunological characterization of BLV proteins synthesized in Escherichia coli.
- A radioimmunoassay detecting the bovine leukaemia virus transmembrane protein gp30 and anti-gp30 antibodies in the serum of cattle.
- Short report: simultaneous occurrence of Dobrava, Puumala, and Tula Hantaviruses in Slovakia.
- Chimeric virus-like particles as vaccines.
Schools
Oregon Health Sciences University
Sioux Falls Fam Prac Res
Doctors Specialties
- Family Medicine
Accepted Insurances
- Choice Plus POS II
- Assurant Health
- Bakery & Confectionary Union Plan
- Blue Card PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Choice Health PPO
- First Health (Coventry Health Care) PPO
- GEHA
- Group Health Cooperative
- HealthSmart
- Humana
- Mail Handlers Benefit Plan (MHBP)
- MedHealthInsurance
- Medicare MCR
- Meritain Health
- MultiPlan PPO
- NGS CoreSource
- Old Surety Life Insurance CompanyMedicare MCR
- PacificSource
- SelectHealth
- Thrivent Financial
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
- Wells Fargo Insurance
- Worker's Compensation WC
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Oregon Health & Science University School of Medicine
Drug Facts
| NPI NUMBER | 1730120718 | |
| NPPES Provider LastName | ULRICH | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 590442119 | |
| NPPES Provider State | MT | |
| Specialty Description | Family Practice | |
| Total Claim Count | 10632.0 | |
| Distinct Opioid Count | 13.0 | |
| Opioid Claim Count | 1125.0 | |
| Percent Opioid Claims | 10.58 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730120718 |
| Last Name Of The Provider | ULRICH |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Dwight Hager, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas A. Woerner, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin McCrea, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lori Forseth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eugene L. Richardson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janice M. Fordham, MD
This Doctor is OpenDoctor Recommended.
|